29.04 
0.07(0.24%) May 24, 4:00PM EDT|After Hours
:
29.02 0.02 (0.07%) May 24, 7:32PM EDT
| Prev Close: | 29.11 |
|---|
| Open: | 28.90 |
|---|
| Bid: | 28.77 x 300 |
|---|
| Ask: | 29.95 x 200 |
|---|
| 1y Target Est: | 31.57 |
|---|
| Beta: | 0.81 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 28.68 - 29.11 |
|---|
| 52wk Range: | 21.40 - 31.15 |
|---|
| Volume: | 35,082,013 |
|---|
| Avg Vol (3m): | 33,862,500 |
|---|
| Market Cap: | 205.99B |
|---|
| P/E (ttm): | 13.90 |
|---|
| EPS (ttm): | 2.09 |
|---|
| Div & Yield: | 0.96 (3.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Pfizer’s Setback and 5 Top Stories Affecting Dow Healthcare Stocks This Weekat Wall St. Cheat Sheet(Sat 2:19PM EDT)
- Tackling Cancer: Pancreatic Cancer's Biggest Current & Upcoming Playersat Motley Fool(Sat 12:15PM EDT)
- Obamacare Will Bring Drug Industry $35 Billion In Profitsat Forbes(Sat 10:29AM EDT)
- Stalled Progress in the Fight Against HIV?at Motley Fool(Sat 8:32AM EDT)
- Big Pharma Learned The Wrong Marketing Lessonat Forbes(Sat 8:30AM EDT)
- Pfizer Will Reward Shareholders With Zoetis Spin-Offat Seeking Alpha(Sat 5:28AM EDT)
- Final Glance: Pharmaceuticals companiesAP(Fri, May 24)
- Pfizer Discontinues Its Inotuzumab Evaluation and 2 Other Dow Movers to Watchat Wall St. Cheat Sheet(Fri, May 24)
- Midday Glance: Pharmaceuticals companiesAP(Fri, May 24)
- BofA Looks For Branch Buyers, Pfizer’s Early Spinoff of Zoetis, and 2 More Hot Stocksat Wall St. Cheat Sheet(Fri, May 24)
- [video] Seib & Wessel: The IRS Just Won’t Go Awayat MarketWatch(Fri, May 24)
- Early Glance: Pharmaceuticals companiesAP(Fri, May 24)
- [$$] Pfizer Set for Higher Earnings Per Shareat Barrons.com(Fri, May 24)
- Pfizer Has Potential To Grow Despite Decreasing Salesat Seeking Alpha(Fri, May 24)
- Five Key Things About the SAC Insider Caseat Bloomberg(Fri, May 24)
Key Statistics
| Forward P/E (1 yr): | 12.36 |
|---|
| P/S (ttm): | 3.58 |
|---|
| Ex-Dividend Date: | 08-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.22 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.58 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 5.46 |
|---|
Business Summary
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care phys...
View More